RYAN SU: Open Payments
NPI 1487383675 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,416 in 132 payments from 32 companies in 2025. Trend: 2023 $2,701 · 2024 $2,943 · 2025 $2,416
Food & beverage: $2,416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $418 |
| Otsuka America Pharmaceutical, Inc. | 11 | $254 |
| Novo Nordisk Inc | 16 | $219 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $162 |
| Lilly USA, LLC | 7 | $128 |
| Phathom Pharmaceuticals, Inc. | 8 | $109 |
| Radius Health, Inc. | 3 | $90 |
| PFIZER INC. | 4 | $89 |
| Axsome Therapeutics, Inc. | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
Products named: REXULTI, UBRELVY, XIFAXAN, VOQUEZNA, VRAYLAR, NURTEC ODT, MOUNJARO, Auvelity.
Industry payments across GA — which companies pay providers there.
